Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$79.51 USD
+0.03 (0.04%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $79.50 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 15% (38 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.87 | 9.99 |
Current Quarter Estimate | 0.99 | 1.59 | 61.00 |
Year Ago Quarter Estimate | 1.07 | -0.94 | 54.84 |
Next Quarter Estimate | 1.00 | 1.70 | 63.00 |
Next Year Estimate | 4.13 | 6.78 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 2.49 | 21.20 | 15.67 |
Next Year | 0.49 | 6.60 | 11.34 |
Last 5 Years | 17.00 | 0.10 | 8.10 |
Next 5 Years | 11.10 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 19.87 | 3.07 |
Price/Book (MRQ) | 3.75 | 1.83 |
Price/Cash Flow (MRFY) | 15.68 | 10.75 |
Dividend Yield | 0.51% | 0.00% |
Net Profit Margin (TTM) | 19.28% | -70.47% |
Return on Equity (TTM) | 20.32% | -48.41% |
Debt to Equity (MRQ) | 0.02 | 1.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.